Literature DB >> 8306325

Tumor-suppressive activity of N03 gene product in v-src-transformed rat 3Y1 fibroblasts.

T Ozaki1, S Sakiyama.   

Abstract

The expression of the N03 gene was significantly reduced in a variety of transformed cells, compared with that in parental rat 3Y1 fibroblasts. To understand the possible role(s) of its product, we have obtained transfectants expressing N03 gene from v-src-transformed 3Y1 cells. Two clones, which overexpressed N03 mRNA, showed a flatter phenotype, a reduced rate of growth, and a decreased ability to grow in soft agar. One of the clones which maintained N03 expression was completely suppressed in forming tumors in nude mice. These data suggest that the N03 gene product may have a suppressive ability on transformed phenotypes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306325

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Isolation of transformation suppressor genes by cDNA subtraction: lumican suppresses transformation induced by v-src and v-K-ras.

Authors:  N Yoshioka; H Inoue; K Nakanishi; K Oka; M Yutsudo; A Yamashita; A Hakura; H Nojima
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Suppression of v-src transformation by the drs gene.

Authors:  H Inoue; J Pan; A Hakura
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

3.  Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture.

Authors:  L Z Topol; M Marx; D Laugier; N N Bogdanova; N V Boubnov; P A Clausen; G Calothy; D G Blair
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Structure of neuroblastoma suppressor of tumorigenicity 1 (NBL1): insights for the functional variability across bone morphogenetic protein (BMP) antagonists.

Authors:  Kristof Nolan; Chandramohan Kattamuri; David M Luedeke; Elizabeth B Angerman; Scott A Rankin; Mariana L Stevens; Aaron M Zorn; Thomas B Thompson
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

5.  Isolation and characterization of a novel mitogenic regulatory gene, 322, which is transcriptionally suppressed in cells transformed by src and ras.

Authors:  X Lin; P J Nelson; B Frankfort; E Tombler; R Johnson; I H Gelman
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

6.  Chromosome mapping of the mouse and rat homologs of the human DAN gene, D1S1733E.

Authors:  Y Matsuda; T Ozaki; H Enomoto; T Saito; S Sakiyama
Journal:  Mamm Genome       Date:  1996-09       Impact factor: 2.957

7.  Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetes.

Authors:  Hiroki Kobayashi; Helen C Looker; Eiichiro Satake; Francesca D'Addio; Jonathan M Wilson; Pierre Jean Saulnier; Zaipul I Md Dom; Kristina O'Neil; Katsuhito Ihara; Bozena Krolewski; Hannah S Badger; Adriana Petrazzuolo; Domenico Corradi; Andrzej Galecki; Parker C Wilson; Behzad Najafian; Michael Mauer; Monika A Niewczas; Alessandro Doria; Benjamin D Humphreys; Kevin L Duffin; Paolo Fiorina; Robert G Nelson; Andrzej S Krolewski
Journal:  Sci Transl Med       Date:  2022-08-10       Impact factor: 19.319

8.  GnRH-mediated DAN production regulates the transcription of the GnRH receptor in gonadotrope cells.

Authors:  Rakel López de Maturana; Bronwen Martin; Robert P Millar; Pamela Brown; Lindsay Davidson; Adam J Pawson; Moira R Nicol; J Ian Mason; Perdita Barran; Zvi Naor; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

9.  3T3 cell lines stably expressing Pax6 or Pax6(5a)--a new tool used for identification of common and isoform specific target genes.

Authors:  Yury Kiselev; Tonje Engevik Eriksen; Siri Forsdahl; Lan Huong Thi Nguyen; Ingvild Mikkola
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

10.  Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.

Authors:  Takuma Matsumura; Jiro Terada; Taku Kinoshita; Yoriko Sakurai; Misuzu Yahaba; Kenji Tsushima; Seiichiro Sakao; Kengo Nagashima; Toshinori Ozaki; Yoshio Kobayashi; Takaki Hiwasa; Koichiro Tatsumi
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.